IMMUNE PHARMACEUTICALS
Immune Pharmaceuticals Inc. (NASDAQ OMX First North Premier: IMNP; OTCQX: IMNP,) applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The company’s lead product candidate, Bertilimumab, is entering Phase II clinical studies for moderate-to-severe ulcerative colitis and bullous pemphigoid, with additional studies planned for Crohn’s disease and severe asthma.
IMMUNE PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2010-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.immunepharmaceuticals.com
Total Employee:
11+
Status:
Active
Contact:
914-606-3500
Total Funding:
62.2 M USD
Technology used in webpage:
SPF Amazon Amazon Virginia Region NameBright
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2012-11-08 | EpiCept Corporation | EpiCept Corporation acquired by Immune Pharmaceuticals | N/A |
Official Site Inspections
http://www.immunepharmaceuticals.com
- Host name: ec2-13-223-25-84.compute-1.amazonaws.com
- IP address: 13.223.25.84
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Immune Pharmaceuticals"
Immune Pharmaceuticals - Crunchbase Company …
Immune Pharmaceuticals Inc. (NASDAQ OMX First North Premier: IMNP; OTCQX: IMNP,) applies a personalized approach to treatment, developing …See details»
Immune Pharmaceuticals Inc (IMNPQ) Profile - The Globe and Mail
See the company profile for Immune Pharmaceuticals Inc (IMNPQ) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Investor Information - immunepharma.com
Immune Pharmaceuticals is on a mission to improve patients’ lives through targeted medicine. The company is well-funded by a diverse investment base. Clinical work focuses on severe …See details»
Immune Pharmaceuticals Inc. Information - RocketReach
Immune Pharmaceuticals Inc. (OTCQB: IMNP) is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Immune’s …See details»
Management Team - immunepharma.com
Elliot Maza was appointed Chief Executive Officer of Immune Pharmaceuticals in September 2017, after serving in this capacity on an interim basis since April 2017 and as a Director since …See details»
Immune Pharmaceuticals Inc. - LinkedIn
Immune Pharmaceuticals Inc. (OTCQB: IMNP) is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Immune’s …See details»
About Immune Pharmaceuticals
She is Senior Vice President, Medical Affairs and Corporate Communications at IMMUNE Pharmaceuticals. Dr. Hehenberger founded an organization called Lyfebulb, to help others …See details»
Immune Pharmaceuticals Inc. Overview - SignalHire
Its headquarters is located at Fort Lee, New Jersey, USA. The number of employees ranges from 1 to 25. The Immune Pharmaceuticals Inc. annual revenue is estimated at < 1M. Total funding …See details»
Immune Pharmaceuticals - Craft
Aug 3, 2022 Immune Pharmaceuticals, together with its subsidiaries is a clinical stage biopharmaceutical company specializing in the development and commercialization of novel …See details»
Immune Pharmaceuticals - Crustdata Company Profile, Funding …
Immune Pharmaceuticals Inc. (NASDAQ OMX First North Premier: IMNP; OTCQX: IMNP,) applies a personalized approach to treatment, developing novel, highly targeted antibody …See details»
Immune Pharmaceuticals - Company Profile - Tracxn
Aug 24, 2024 Immune Pharmaceuticals - Developer of therapeutic agents for the treatment of immunologic and inflammatory diseases. Public Company. Raised a total funding of $3.85M …See details»
Immune Pharmaceuticals - PitchBook
Immune Pharmaceuticals Inc is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. The company's lead …See details»
Company Immune Pharmaceuticals, Inc. OTC Markets
Aug 25, 2013 Immune Pharmaceuticals Inc., is a clinical-stage biopharmaceutical company. It is engaged in the development of novel targeted therapeutic agents in the fields of immunology, …See details»
Immune Pharmaceuticals Inc. (IMNP.ST) - Yahoo Finance Canada
See the company profile for Immune Pharmaceuticals Inc. (IMNP.ST) including business summary, industry/sector information, number of employees, business summary, corporate …See details»
Immune Pharmaceuticals - Funding, Financials, Valuation & Investors
Immune Pharmaceuticals is registered under the ticker NASDAQ:IMNP . Stock Symbol NASDAQ:IMNP ; IPO Date Aug 21, 2014; Delisted Date Jul 26, 2018; Stock chart by . ...See details»
Immune Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical …
This is an open-label, proof-of-concept, single group study in adult patients with newly diagnosed, moderate to extensive BP. The study will consist of three periods: a screening period of up to …See details»
Immune Pharmaceuticals - Products, Competitors, Financials, …
Immune Pharmaceuticals primarily serves individuals seeking affordable healthcare products and savings on medications. It was founded in 2010 and is based in Fort Lee, New Jersey. …See details»
Immune Pharmaceuticals Inc (IMNPQ) Stock Price and News
Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Immune's lead program, …See details»
Board of Directors | Immunepharma.com
Melini Capital has been an early and significant investor in Immune Pharmaceuticals. Daniel built his own management consulting firm over 15 years to 25 professionals advising boards of …See details»
Establishing an immune correlate of protection for Nipah virus in ...
1 day ago The limited but recurrent outbreaks of the zoonotic Nipah virus (NiV) infection in humans, its high fatality rate, and the potential virus transmission from human to human make …See details»